Speciality Medicines Limited Share Price Today

Speciality Medicines Limited – Company Overview

Speciality Medicines Limited is a Public company incorporated on 05 Dec 2021. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 1,10,00,00,00.00 and its paid-up capital is Rs. 6,43,57,960.

Speciality Medicines Limited was originally incorporated as Speciality Medicines Private Limited under the Companies Act, 2013. Following a special resolution passed by shareholders at the EGM on April 4, 2024, the company was converted into a public limited company and renamed Speciality Medicines Limited.

Speciality Medicines Limited is a fast-growing pharmaceutical company focused on high-value specialty drugs across therapeutic areas like oncology, nephrology, and critical care. With the support of a trusted and extensive global network of manufacturers and distributors, Speciality Medicines Limited sources pharmaceutical products from over 40 countries.

Speciality Medicines Limited Share Price, Share Details as of March 31, 2025

Speciality Medicines Limited Incorporation Details

Speciality Medicines Limited Board of Directors

Speciality Medicines Limited Principal Business Activities

Speciality Medicines Limited Particulars of Holding, Subsidiaries, &Associate Companies

The Company does not have any Subsidiary Company.

Speciality Medicines Limited Shareholding Pattern (as on 2025)

Q: What is the face value of Speciality Medicines Ltd (SMCL) shares?
Answer: The face value of Speciality Medicines Ltd (SMCL) is ₹10 per equity share.

Q: What is the minimum lot size for buying SMCL shares through WWIPL?
Answer: The minimum lot size for Speciality Medicines Ltd shares is 100 equity shares.

Q: How can I buy Speciality Medicines Ltd unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy Speciality Medicines Ltd shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Speciality Medicines Ltd a good idea?
Answer: Investors often evaluate SMCL based on its growing presence in specialty pharmaceuticals, financial performance, global sourcing network, and long-term opportunities in high-value therapeutic segments.

Q: Why do investors buy Speciality Medicines Ltd shares before a potential IPO?
Answer: Investors seek early exposure to a fast-growing pharmaceutical company before a public listing, aiming to participate in future value creation and liquidity opportunities.

Q: What business does Speciality Medicines Ltd operate in?
Answer: Speciality Medicines Ltd is engaged in the marketing and distribution of specialty pharmaceutical products, focusing on therapeutic areas such as oncology, nephrology, and critical care, with sourcing from over 40 countries.

Q: What makes Speciality Medicines Ltd different from other unlisted pharmaceutical companies?
Answer: The company specializes in high-value specialty medicines and has built an extensive global sourcing and distribution network serving both domestic and international markets.

Q: What are the key growth drivers for Speciality Medicines Ltd?
Answer: Rising demand for specialty pharmaceuticals, expansion into international markets, product registrations, growing healthcare expenditure, and a wider distribution network are key growth drivers.

Q: What factors affect the valuation of SMCL shares?
Answer: Revenue growth, profitability, expansion into global markets, product portfolio, operating margins, and demand for specialty medicines are key valuation drivers.

Q: Are Speciality Medicines Ltd shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my SMCL shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and availability.

Q: What documents are required to buy Speciality Medicines Ltd shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in SMCL shares?
Answer: Investors should consider regulatory risks, pricing pressure, competition, product concentration, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Speciality Medicines Ltd investments?
Answer: WWIPL provides company updates, transaction assistance, market insights, and investment support to help investors stay informed.

Q: How long does it take for SMCL shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Speciality Medicines Ltd?
Answer: Investors should assess the company's financial performance, product portfolio, global distribution network, profitability, valuation, and long-term growth prospects.

Q: Can Speciality Medicines Ltd benefit from the growing specialty pharmaceuticals market?
Answer: Yes. Increasing demand for specialty drugs, expansion into international markets, and rising healthcare spending may support the company's long-term growth.